In contrast to TERT promoter mutation, the prognostic impact of MGMT methylation was not dependent on other confounding factors including the status of TERT promoter mutation, emphasizing the important role of MGMT methylation as an independent prognostic marker in gliomas. This evidence concerns the gene TERT and central nervous system cancer.